Gabapentin Solution
Product Images NDC 72162-1318

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 72162-1318). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Equation (Figure 01)

Equation (Figure 01)
This formula calculates creatinine clearance (CLCr) based on age, weight, and serum creatinine level for both male and female patients. It considers a reduction factor for female patients by multiplying the result by 0.85.*
FDA Label Image

Chemical Structure (Figure 02)

FDA Label Image

Figure 1 (Figure 03)

FDA Label Image

Figure 2 (Figure 04)

FDA Label Image

Figure 3 (Figure 05)

FDA Label Image

Figure 4 (Figure 06)

FDA Label Image

Logo (Figure 07)

Logo (Figure 07)
Acella Pharmaceuticals, LLC is a pharmaceutical company.*
FDA Label Image

Label (Lbl721621318)

Label (Lbl721621318)
This is a description of a medication called Gabapentin Oral Solution at a concentration of 250 mg/5 mL. It includes warnings about keeping the medication out of reach of children, storage instructions, and information about contacting a Poison Control Center in case of accidental overdose. The text also provides details for pharmacists on dispensing the medication and where to find patient package inserts and a medication guide online. The medication is manufactured by Acella Pharmaceuticals, LLC and distributed by Bryant Ranch Prepack, Inc. in Burbank, CA, USA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.